title: Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.
abstract: BACKGROUND
  Azithromycin has been widely used for Mycoplasma genitalium treatment internationally. However, the eradication efficacy has substantially declined recent decade. In Russia, josamycin (another macrolide) is the recommended first-line treatment for M. genitalium infections, however, no data regarding treatment efficacy with josamycin and resistance in M. genitalium infections have been internationally published. We examined the M. genitalium prevalence in males attending an STI clinic in Moscow, Russia from December 2006 to January 2008, investigated treatment efficacy with josamycin in male urethritis, and monitored the M. genitalium DNA eradication dynamics and selection of macrolide resistance in M. genitalium during this treatment.
  
  
  METHODS
  Microscopy and real-time PCRs were used to diagnose urethritis and non-viral STIs, respectively, in males (n = 320). M. genitalium positive patients were treated with recommended josamycin regimen and treatment efficacy was monitored using quantitative real-time PCR. Macrolide resistance mutations were identified using sequencing of the 23S rRNA gene.
  
  
  RESULTS
  Forty-seven (14.7%) males were positive for M. genitalium only and most (85.1%) of these had symptoms and signs of urethritis. Forty-six (97.9%) males agreed to participate in the treatment efficacy monitoring. All the pre-treatment M. genitalium specimens had wild-type 23S rRNA. The elimination of M. genitalium DNA was substantially faster in patients with lower pre-treatment M. genitalium load, and the total eradication rate was 43/46 (93.5%). Of the six patients with high pre-treatment M. genitalium load, three (50%) remained positive post-treatment and these positive specimens contained macrolide resistance mutations in the 23S rRNA gene, i.e., A2059G (n = 2) and A2062G (n = 1).
  
  
  CONCLUSIONS
  M. genitalium was a frequent cause of male urethritis in Moscow, Russia. The pre-treatment M. genitalium load might be an effective predictor of eradication efficacy with macrolides (and possibly additional antimicrobials) and selection of macrolide resistance. Additional in vivo and in vitro data are crucial to support the recommendation of using josamycin as first-line treatment for M. genitalium infections in Russia. It would be valuable to develop international M. genitalium management guidelines, and quantitative diagnostic PCRs determining also M. genitalium load and resistance mutations (for macrolides and ideally also moxifloxacin) should ideally be recommended.
authors: Alexander
authors: A
authors: Guschin
authors: Pavel
authors: P
authors: Ryzhikh
authors: Tatiana
authors: T
authors: Rumyantseva
authors: Mikhail
authors: M
authors: Gomberg
authors: WHO Collaborating Centre for Gonorrhoea and other STIs, National Reference Laboratory for Pathogenic Neisseria, Örebro University Hospital, Örebro, Sweden. magnus.unemo@orebroll.se.
authors: Magnus
authors: M
authors: Unemo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D058491:Bacterial Load / Q000187:drug effects / Q000235:genetics; D004269:DNA, Bacterial / Q000032:analysis / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000187:drug effects*; D006801:Humans; D015570:Josamycin / Q000494:pharmacology / Q000627:therapeutic use*; D018942:Macrolides / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009175:Mycoplasma Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D045704:Mycoplasma genitalium / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D015995:Prevalence; D060888:Real-Time Polymerase Chain Reaction; D012426:Russia / Q000453:epidemiology; D017211:Treatment Failure; D016896:Treatment Outcome; D014526:Urethritis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D018942:Macrolides; D015570:Josamycin
references: Int J STD AIDS. 2010 Nov;21(11):729-37
references: 21187352
references: Clin Microbiol Infect. 2010 Nov;16(11):1649-55
references: 20047607
references: Clin Microbiol Rev. 2011 Jul;24(3):498-514
references: 21734246
references: Am J Obstet Gynecol. 2012 Jun;206(6):476.e1-8
references: 22483084
references: J Eur Acad Dermatol Venereol. 2013 Feb;27(2):e217-23
references: 22672184
references: Clin Infect Dis. 2013 Apr;56(7):934-42
references: 23223595
references: Clin Infect Dis. 2013 Apr;56(8):1094-100
references: 23300236
references: PLoS One. 2013;8(4):e61481
references: 23593483
references: J Clin Microbiol. 2013 Jul;51(7):2245-9
references: 23658265
references: Int J STD AIDS. 2013 Oct;24(10):822-8
references: 24052013
references: Clin Infect Dis. 2014 Mar;58(5):631-7
references: 24280088
references: J Clin Pathol. 2014 Sep;67(9):817-20
references: 24982440
references: Clin Infect Dis. 2014 Jul 1;59(1):24-30
references: 24729494
references: Clin Infect Dis. 2015 Apr 15;60(8):1228-36
references: 25537875
references: Antimicrob Agents Chemother. 2001 Jan;45(1):319-23
references: 11120988
references: Antimicrob Agents Chemother. 2001 Oct;45(10):2958-60
references: 11557502
references: J Bacteriol. 2001 Dec;183(23):6898-907
references: 11698379
references: Lancet. 2002 Mar 2;359(9308):765-6
references: 11888591
references: Mol Cell. 2002 Jul;10(1):117-28
references: 12150912
references: J Infect Dis. 2003 Feb 15;187(4):650-7
references: 12599082
references: Antimicrob Agents Chemother. 2004 Feb;48(2):460-5
references: 14742195
references: Antimicrob Agents Chemother. 1992 Apr;36(4):870-2
references: 1503451
references: Antimicrob Agents Chemother. 1995 Dec;39(12):2770-3
references: 8593017
references: Sex Transm Infect. 2005 Dec;81(6):458-62
references: 16326846
references: Sex Transm Infect. 2005 Dec;81(6):463-6
references: 16326847
references: Sex Transm Infect. 2007 Jun;83(3):237-41
references: 17090566
references: Sex Transm Infect. 2008 Feb;84(1):72-6
references: 17932127
references: Int J STD AIDS. 2008 Oct;19(10):676-9
references: 18824619
references: Clin Infect Dis. 2008 Dec 15;47(12):1546-53
references: 18990060
references: J Eur Acad Dermatol Venereol. 2009 Mar;23(3):268-76
references: 19207643
references: Clin Infect Dis. 2009 Jun 15;48(12):1649-54
references: 19438399
references: Int J STD AIDS. 2009 Jul;20(7):458-64
references: 19541886
references: J Eur Acad Dermatol Venereol. 2009 Oct;23(10):1164-72
references: 19453801
references: J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1246-53
references: 19453773
references: Clin Infect Dis. 2010 Nov 15;51(10):1160-6
references: 20942656
references: Clin Infect Dis. 2011 Jan 15;52(2):163-70
references: 21288838